With some premix products continuous medication is required and there is a pronounced drop-off in performance once it is discontinued. In contrast, treatment with ECONOR controls enteric diseases effectively during and post-medication. 
 
The table next below describes results from a study confirming that in the face of a naturally occurring ileitis challenge, a single application of ECONOR for 21 days post-weaning effectively controlled ileitis during and beyond the medication period and significantly reduced the clinical signs of the disease.
 

CONTROL DURING AND BEYOND THE MEDICATION PERIOD

Disease control beyond the medication period ensures a positive effect on performance. In the same study, with a single application of ECONOR post-weaning, Alexopoulos demonstrated a statistically different feed conversion and average daily gain post-medication compared to a positive control group, resulting in an improved cost benefit (next below).
 

IMPROVED POST-MEDICATION PERFORMANCE

Other studies confirm excellent feed conversion efficacy and weight gain, resulting in increased productivity.
 

INCREASED PRODUCTIVITY